Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $250.11 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $66.27 | 4 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $44.94 | 2 | $0 (2019) |
| Merck Sharp & Dohme LLC | $26.35 | 2 | $0 (2022) |
| Mallinckrodt Hospital Products Inc. | $22.55 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $21.40 | 1 | $0 (2019) |
| Amgen Inc. | $18.76 | 1 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $18.06 | 1 | $0 (2019) |
| Alkermes, Inc. | $16.63 | 1 | $0 (2019) |
| TETRAPHASE PHARMACEUTICALS, INC. | $15.15 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.55 | 1 | Mallinckrodt Hospital Products Inc. ($22.55) |
| 2023 | $37.51 | 2 | Amgen Inc. ($18.76) |
| 2022 | $15.45 | 1 | Merck Sharp & Dohme LLC ($15.45) |
| 2021 | $21.05 | 1 | Janssen Pharmaceuticals, Inc ($21.05) |
| 2019 | $141.69 | 8 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($44.94) |
| 2018 | $11.86 | 1 | Janssen Pharmaceuticals, Inc ($11.86) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: CRITICAL CARE | ||||||
| 09/07/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/29/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Cardiology | ||||||
| 05/18/2022 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), ISENTRESS, DIFICID | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/30/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/10/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/30/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/22/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug), JYNARQUE | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: NEPHROLOGY | ||||||
| 04/05/2019 | TETRAPHASE PHARMACEUTICALS, INC. | Xerava (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Complicated Intra-Abdominal Infections | ||||||
| 04/04/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: CNS | ||||||
| 02/14/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/10/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/24/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 447 | 610 | $333,559 | $51,014 |
| 2022 | 10 | 424 | 596 | $240,263 | $39,527 |
| 2021 | 10 | 652 | 878 | $264,044 | $62,320 |
| 2020 | 11 | 788 | 1,039 | $260,206 | $80,095 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 127 | 224 | $124,547 | $20,271 | 16.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 110 | 173 | $58,982 | $10,382 | 17.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 70 | 70 | $76,556 | $9,405 | 12.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 82 | 85 | $52,276 | $7,332 | 14.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 58 | 58 | $21,198 | $3,624 | 17.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 108 | 202 | $103,322 | $16,024 | 15.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 110 | 179 | $61,056 | $9,727 | 15.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 58 | 58 | $22,658 | $4,458 | 19.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $17,731 | $2,631 | 14.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 43 | 44 | $19,243 | $2,421 | 12.6% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 19 | 20 | $3,300 | $1,058 | 32.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 20 | 20 | $5,458 | $1,057 | 19.4% |
| 99318 | Nursing facility annual assessment, typically 30 minutes | Facility | 2022 | 11 | 11 | $2,585 | $802.19 | 31.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 17 | 24 | $2,600 | $684.40 | 26.3% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 21 | 21 | $2,310 | $664.04 | 28.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 143 | 229 | $76,657 | $18,084 | 23.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 163 | 264 | $59,608 | $14,703 | 24.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 135 | 140 | $45,037 | $11,270 | 25.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 36 | 37 | $26,498 | $5,420 | 20.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 66 | 68 | $16,197 | $3,746 | 23.1% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 26 | 27 | $15,069 | $3,710 | 24.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 41 | 65 | $10,296 | $1,887 | 18.3% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2021 | 16 | 19 | $5,211 | $1,419 | 27.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 11 | 11 | $4,312 | $1,085 | 25.2% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 15 | 18 | $5,159 | $997.23 | 19.3% |
About Dr. Karim Nazer, M.D
Dr. Karim Nazer, M.D is a Infectious Disease healthcare provider based in Florence, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174613004.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karim Nazer, M.D has received a total of $250.11 in payments from pharmaceutical and medical device companies, with $22.55 received in 2024. These payments were reported across 14 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($250.11).
As a Medicare-enrolled provider, Nazer has provided services to 2,311 Medicare beneficiaries, totaling 3,123 services with total Medicare billing of $232,957. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Other Specialties Infectious Disease, Infectious Disease
- Location Florence, SC
- Active Since 10/13/2006
- Last Updated 10/03/2024
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1174613004
Products in Payments
- XARELTO (Drug) $66.27
- XIFAXAN (Drug) $44.94
- TERLIVAZ (Drug) $22.55
- ENTRESTO (Drug) $21.40
- Repatha (Biological) $18.76
- SAMSCA (Drug) $18.06
- ARISTADA (Drug) $16.63
- PIFELTRO (Drug) $15.45
- Xerava (Drug) $15.15
- DIFICID (Drug) $10.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Florence
Julio Arroyo, Md, MD
Infectious Disease — Payments: $15,887
Dr. Ramesh Bharadwaj, M.d, M.D
Infectious Disease — Payments: $2,027
Dr. James Greenman, Md, MD
Infectious Disease — Payments: $1,312
Dr. Yamil Michelen Alvarez, Md, MD
Infectious Disease — Payments: $1,045
Barbara Okafor, Md, MD
Infectious Disease — Payments: $200.31
Dr. Monirul Sajib, Md, MD
Infectious Disease — Payments: $77.31